Dynamis Therapeutics, Inc.
Dynamis Therapeutics, Inc.
Categories
Biotech Pharmaceutical
About
Dynamis Therapeutics is focused on the discovery and development of therapeutic pharmaceuticals to treat and prevent diabetic complications resulting from glucose induced glycation and oxidative stress. Now, Dynamis brings its discovery out of the laboratory with MEG 21 ? a unique skin treatment that delivers the compound Supplaminer deep into skin to reduce inflammation and free radicals, allow normal collagen production and reverse cross-linking.
Get Updates
from LSPA
Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry, and so much more!
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.